Business
Director Share Dealing
Director Share Dealing.
About this update from Futura Medical Plc
[{"type":"text","content":"\n \nRNS Number : 8571B Futura Medical PLC 09 April 2013 \n \n\n\n\n\n\nFor immediate release \n\n\n9 April 2013\n\n\n\n\n \nFutura Medical plc \n(\"Futura\" or \"the Company\")\nDirector Share Dealings\nFutura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has received notification that Jonathan Freeman, the senior non-executive director of the Company, has today transferred 6,802 shares in the Company from certificated form in his name into his Crest account at Hargreaves Lansdown.\nNo disposal has taken place for the purposes of the AIM Rules for Companies. Mr Freeman's aggregate beneficial holding remains unchanged at 6,802 ordinary shares.\n \n \n \nFor any further information please contact:\n \n\n\n\n\nFutura Medical plc\n\n\n \n\n\n\n\nJames Barder, Chief Executive\n\n\nTel: +44 (0)1483 685 670\n\n\n\n\nmail to: [email protected]\n\n\nwww.futuramedical.com\n\n\n\n\n \n\n\n \n\n\n\n\n \nNomura Code Securities Limited\n\n\n \n\n\n\n\nPhil Walker / Giles Balleny\n\n\nTel:+44 (0)20 7776 1200\n\n\n\n\n \n\n\n \n\n\n\n\nFor media enquiries please contact:\n\n\n \n\n\n\n\n \n\n\n \n\n\n\n\nBuchanan\n\n\n \n\n\n\n\nMark Court / Fiona Henson / Sophie Cowles\n\n\nTel: +44 (0)20 7466 5000\n\n\n\n\n \n \nNotes to Editors\n \nFutura Medical plc\n \nFutura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.\n \nFutura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.\nwww.futuramedical.com \n\nThis information is provided by RNSThe company news service from the London Stock Exchange END RDSIPMFTMBIMBRJ\n ","length":5106,"tagName":"div"}]